Jakob Dupont
CIK 1553335 · EVP, Head of R&D · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$213.1K
Companies
5
Total Filings
51
Lifetime Open-Market Net
-$1.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PYXS | Director | 38,741 | $2.91 | $112.7K | -$107.1K | 6 | 2026-07-02 |
| BOLT | Director | — | $4.02 | — | $0 | 5 | 2026-06-11 |
| ATRA | EVP, Head of R&D | 11,632 | $7.81 | $90.8K | -$573.0K | 15 | 2023-03-06 |
| Apexigen, Inc. (APGNW) Delisted | Director | — | $0.03 | — | $0 | 1 | 2022-10-03 |
| GOSS | Chief Medical Officer | 46,500 | $0.21 | $9.5K | -$631.5K | 3 | 2020-02-19 |
Recent Filings · Page 4 of 6
51 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-31 | GOSS | Mixed | — | -$181.8K | EDGAR |
| 2019-03-26 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2016-10-11 | — | Grant (A) | +12,500 | $0 | |
| 2016-01-12 | — | Mixed | — | -$38.6K | |
| 2016-01-08 | — | Sell (S) | −2,162 | -$48.2K | |
| 2015-12-29 | — | Grant (A) | — | $0 | |
| 2015-12-14 | — | Mixed | — | -$39.8K | |
| 2015-11-12 | — | Mixed | — | -$41.5K | |
| 2015-10-27 | — | Mixed | — | -$77.2K | |
| 2015-08-12 | — | Mixed | — | -$44.2K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.